Results 71 to 80 of about 2,912 (167)
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials
Leukodystrophies are progressive single gene disorders affecting the white matter of the brain. Several gene therapy trials are in progress to address the urgent unmet need for this patient population.
Jasna Metovic +3 more
doaj +1 more source
GM2 activator protein deficiency, mimic of Tay-Sachs disease
GM2 Gangliosidoses are a group of autosomal recessive genetic disorders caused by intra-lysosomal deposition of ganglioside GM2 mainly in the neuronal cells.
Sheela Nampoothiri +5 more
core +1 more source
Thesis (Master, Neuroscience Studies) -- Queen's University, 2015-12-11 17:45:21.072GM2 gangliosidoses are a group of neurodegenerative disorders, characterized by the malfunctioning β-Hexosaminidase A (HexA) enzyme, for which there is no current ...
Osmon, Karalaina
core
Similarities and differences in the late-onset GM2 gangliosidoses: Tay-Sachs and Sandhoff diseases. [PDF]
Lewis CJ +16 more
europepmc +1 more source
Symptomatic Benefit of Acetyl-DL-Leucine for Cerebellar Ataxia in Juvenile Tay-Sachs Disease: A Pediatric Case and Literature Review. [PDF]
Calisgan K +7 more
europepmc +1 more source
An example for potentially underrated causes of recessive disease in the Greater Middle East: integrative long-read genome and transcriptome sequencing pinpoint a deep-intronic homozygous HEXB candidate founder variant in GM2-gangliosidosis. [PDF]
Bolte A +8 more
europepmc +1 more source
Metabolomic Insights into Lysosomal Storage Diseases: An Untargeted View. [PDF]
Di Carlo G +12 more
europepmc +1 more source

